Product Comparison

  Abbott Rapid Dx North America LLC LFR124 LumiraDx Inc L001000330001

No Image

Sekisui Diagnostics 1039 Cue Health Inc C0201
McKesson # 1087252 1198202 1202548 1149142 1219993
Description Respiratory Test Reader Binaxnow® CLIA Waived Respiratory Test Reader LumiraDx™ CLIA Waived Respiratory Test Reader LumiraDx™ TOP Program Respiratory Test Reader Acucy™ CLIA Waived Respiratory Test Reader Cue® CLIA Waived
Manufacturer # LFR124L001000330001L016-US01-SB0031039C0201
Brand BinaxNOW®LumiraDx™LumiraDx™ TOP ProgramAcucy™Cue®
Manufacturer Abbott Rapid Dx North America LLCLumiraDx IncLumiraDx IncSekisui DiagnosticsCue Health Inc
    Log In to Order   Log In to Order   Log In to Order   Log In to Order   Log In to Order


Analyzer Type BenchtopBenchtopBenchtopBenchtopHandheld
CLIA Classification CLIA WaivedCLIA Waived for Swab SamplesCLIA Waived
CLIA Classified CLIA WaivedCLIA WaivedCLIA WaivedCLIA Waived
Contents 1 Alere™ Reader, Barcode Scanner, Alere Binaxnow® Tray Pack, Calibration Check Card Pack, Alere™ USB DriveAcucy Reader, Acucy Printer, Acucy Calibration Device, (2) AC/DC Power Converters, Exclusive USB Memory Drive, Acucy System Manual, Printer Roll, Master Password CardCue Reader, Power Adaptor, Power Cord
Country of Origin JapanUnknownUnknownJapanUnknown
Dimensions 125 X 160 X 195 mm73 X 97 X 210 mm73 X 97 X 210 mm120 X 145 X 235 mm (Reader)1-1/2 X 2-7/8 X 2-7/8 Inch
For Use With For Alere™ ReaderFor use with LumiraDx Test Strips / LumiraDx ConnectFor use with Cue Cartridges and Cue Health App on a Mobile Smart Device
Number of Tests 22 Tests
Power Source 100 to 240 VAC, 50/60 Hz100 to 240V, 50/60Hz100 to 240V, 50/60Hz100 to 240 V, 50/60 HzRechargeable Battery
Product Dating McKesson Acceptable Dating: we will ship >= 90 days
Purchase Program Type Standard Purchase AgreementStandard Purchase AgreementPromotional BundleStandard Purchase AgreementStandard Purchase Agreement
Readout Type Touch Screen, PrintoutTouchscreen DisplayTouchscreen DisplayUSB Data Transfer / Printout
Sample Type Nasal Swab / Nasopharyngeal SwabCapillary Blood Sample / Nasal Swab SampleCapillary Blood Sample / Nasal Swab SampleNasal Swab / Nasopharyngeal SwabNasal Swab Sample
Test Name Influenza A + B TestSARS-CoV-2 Ag, SARS-CoV-2 Ab, D-Dimer, Prothrombin Time (INR), SurveillanceInfluenza A + B TestCOVID-19
Time to Results 15 Minute Results15 Minute Results20 Minute Results
UNSPSC Code 4111580841115819411158084111580041115800
User Interface 4-1/3 Inch Touch ScreenHigh Contrast Touch Screen / Barcode ScannerHigh Contrast Touch Screen / Barcode ScannerLCD Touch Screen
Weight 3.3 lbs2.42 lbs.2.42 lbs.1.7 kg (Reader)5.3 oz.
Application Respiratory Test ReaderRespiratory Test ReaderRespiratory Test ReaderRespiratory Test ReaderRespiratory Test Reader
Features and Benefits
  • Alere BinaxNOW® Influenza A & B Card 2 is an in vitro immunochromatographic assay for the qualitative detection of influenza A and B nucleoprotein antigens in nasopharyngeal (NP) swab and nasal swab samples
  • Alere BinaxNOW® Influenza A & B Card 2 must be read by the Alere™ Reader
  • The first rapid antigen influenza test to achieve 510(k) clearance as a Class II assay under the new FDA Reclassification performance requirements
  • The LumiraDx Platform is an innovative, next generation point of care system that combines a small, portable instrument, advanced low cost test strip and seamless digital connectivity
  • Enzyme and immunoassay on a single platform
  • Its proprietary technology enables it to deliver exceptional point of care clinical performance, while being simple and easy to use
  • Performance referenced to laboratory test
  • Portable instrument, seamless connectivit
  • One simple, intuitive test workfow
  • Fast results in minutes
  • All common clinical samples
  • Small sample size including capillary blood
  • Ability to perform Quality Control Tests using LumiraDx Quality Control to meet regulatory compliance requirements
  • 2 x USB ports, RFID reader 13.56 MHz, 0 dBi (EIRP), Bluetooth low-energy 2.4 GHz ISM band, 2400 MHz to 2483.5 MHz, 0.5 dBm (ERP)
  • Lithium ion polymer 7.4 V 5000 mAh battery
  • High contrast touchscreen with a wide viewing angle
  • Uses small sample volumes and multiple convenient sample types, including nasal swab and capillary blood
  • Pipeline of 30+ assays, initially focused on some of the most common conditions being diagnosed or managed with POC testing
  • The LumiraDx SARS-CoV-2 Ag Test has been authorized by FDA under an EUA only for the detection of SARS-CoV-2 nucleocapsid protein
  • The LumiraDx SARS-CoV-2 Ab Test has been authorized by FDA under an EUA only for detecting the presence of total antibodies to SARS-CoV-2
  • LumiraDx TOP Program Starter Pack (7 Kits), Includes Instrument, Kits, Controls, Swabs
  • Innovative Composite Comparator with molecular and culture
  • Read Now or Walk Away mode
  • Results within 15 minutes
  • The Acucy Reader is an optoelectronic instrument that uses a reflectance-based measurement method to evaluate the line signal intensities on the test strip, and a specific algorithm to determine the presence or absence of any target analyte(s)
  • Cue Reader is a durable, intuitive automated processor of test results and is used with Cue tests and the Cue Health App - designed to work with Cue's COVID-19 tests as well as future tests
  • The Cue Reader runs single-use cartridges and communicates the result of the test digitally via Bluetooth® to the Cue Health App
  • The Cue Cartridge Reader features 5 LED indicator lights located on the top of the Cue Cartridge Reader
  • Once the Cue Wand with the nasal sample is inserted into the pre-heated Cue Test Cartridge, the Cue Reader will process the test and communicate the result directly to the Cue Health App on your mobile device via Bluetooth®
  • The lights provide quick feedback on the status of the Cue Cartridge Reader together with the Cue Health App
  • Cue is the first compact, portable molecular self-testing system authorized by the FDA for use at home or on the go, without a prescription
  • Cue COVID-19 tests sold separately